N. TÖZÜN, “Safety of peginterferon alfa-2a (40KD) treatment in patients with chronic hepatitis B infection: An observational, multicenter, open label, non-interventional study in Turkish patients”, Turkish Journal of Gastroenterology, vol. 23, no. 5, pp. 552–559, Jan. 2012.